Haitong Securities Company Limited(600837)
About Shanghai Rightongene Biotechnology Co.Ltd(688217)
Special verification opinions on the deposit and use of raised funds in 2021
Haitong Securities Company Limited(600837) (hereinafter referred to as ” Haitong Securities Company Limited(600837) ” or “sponsor”) is the continuous supervision sponsor of Shanghai Rightongene Biotechnology Co.Ltd(688217) (hereinafter referred to as ” Shanghai Rightongene Biotechnology Co.Ltd(688217) ” or “company”) for initial public offering and listing on the science and innovation board, In accordance with the measures for the administration of securities issuance and listing recommendation business, the guidelines for the supervision of listed companies No. 2 – regulatory requirements for the management and use of raised funds by listed companies (revised in 2022), the Listing Rules of Shanghai Stock Exchange on the science and Innovation Board (revised in December 2020) and other relevant provisions, a special verification was conducted on the deposit and use of the company’s raised funds in 2021. The details are as follows: I. Basic information of raised funds
(I) actual amount of raised funds and time of fund arrival
With the approval of China Securities Regulatory Commission on Approving the registration of Shanghai Rightongene Biotechnology Co.Ltd(688217) initial public offering of shares (zjxk [2021] No. 1126), the company publicly issued 13.9 million RMB common shares (A shares) to the public at an issue price of 18.42 yuan / share, and the total amount of funds raised was 256038 million yuan. After deducting the total amount of issuance expenses (excluding value-added tax) of 61.241 million yuan, the net amount of funds actually raised was 194797 million yuan. All the raised funds have been deposited in the special account of raised funds after they are received. The company has signed a supervision agreement on the storage of the special account of raised funds with the sponsor and the bank storing the raised funds.
Zhonghui Certified Public Accountants (special general partnership) verified the availability of the above raised funds of the company and issued the capital verification report (Zhonghui kuaiyan [2021] No. 4141) on May 11, 2021.
(II) use and balance of raised funds
As of December 31, 2021, the use and balance of the company’s raised funds are as follows:
Project amount (10000 yuan)
The amount of raised funds actually received is 2240380
Less: 260828 yuan paid for issuance expenses excluding tax
Less: the replacement amount of investment projects invested with raised funds in advance with self raised funds is 305440
Less: 315.81 replacement amount paid in advance with self raised funds
Project amount (10000 yuan)
Less: 249537 Yuan directly invested in projects funded by raised funds
Less: balance of financial products purchased, time deposits and structured deposits 1200000
Plus: accumulated income from financial products, time deposits and structured deposits, 178.22
Net interest income less handling charges
As of December 31, 2021, the balance of the raised funds account was 210815
2、 Management of raised funds
(I) management system of raised funds
In order to standardize the management and use of raised funds, improve the efficiency of the use of raised funds and protect the rights and interests of investors, In accordance with the company law of the people’s Republic of China, the securities law of the people’s Republic of China, the Listing Rules of the science and Innovation Board of Shanghai Stock Exchange, the regulatory guidelines for listed companies No. 2 – regulatory requirements for the management and use of raised funds of listed companies, and the self regulatory guidelines for listed companies on the science and Innovation Board of Shanghai Stock Exchange No. 1 – standardized operation and other relevant laws, regulations and normative documents, In combination with the actual situation of the company, the Shanghai Rightongene Biotechnology Co.Ltd(688217) raised funds management system is formulated, which makes clear provisions on the storage and use of raised funds, project implementation management, change of investment projects and supervision of use.
(II) supervision agreement of raised funds
In April 2021, the company signed the tripartite supervision agreement on the storage of special account for raised funds with the sponsor Haitong Securities Company Limited(600837) and the deposit bank of special account for raised funds ( China Merchants Bank Co.Ltd(600036) Shanghai Fengxian sub branch, Shanghai Branch of Guangdong Development Bank Co., Ltd. Bank Of Hangzhou Co.Ltd(600926) Shanghai branch, Bank Of Nanjing Co.Ltd(601009) Shanghai Branch), which defined the rights and obligations of all parties. There is no significant difference between the above agreement and the tripartite supervision agreement (model) on the special account storage of raised funds of Shanghai Stock Exchange, and the company has strictly complied with and performed when using the raised funds.
(III) storage of raised funds in special account
As of December 31, 2021, the deposit of the company’s raised funds in the bank account is as follows:
No. balance of raised funds in bank account of deposit bank (10000 yuan)
1 China Merchants Bank Co.Ltd(600036) 121939758010903 6.02
Shanghai Fengxian sub branch
2 Guangfa Bank Co., Ltd. 95508802058919008191092.11
Shanghai Branch
3 Bank Of Hangzhou Co.Ltd(600926) 3101040160 Shandong Weida Machinery Co.Ltd(002026) 406 34.17
Shanghai Branch
No. balance of raised funds in bank account of deposit bank (10000 yuan)
4 Bank Of Nanjing Co.Ltd(601009) 0301230 Shenzhen Guohua Network Security Technology Co.Ltd(000004) 922 975.85
Shanghai Branch
Total 210815
3、 Actual use of raised funds this year
(I) comparison table of use of raised funds
The actual use of the company’s raised funds in 2021 is detailed in Schedule 1 “comparison table of the use of raised funds”.
(II) advance investment and replacement of raised funds
On June 30, 2021, the company held the 17th meeting of the first board of directors and the 12th meeting of the first board of supervisors, deliberated and approved the proposal on using raised funds to replace self raised funds invested in projects invested with raised funds in advance and paid issuance expenses respectively, and agreed to use raised funds to replace paid issuance expenses of RMB 3.1581 million and self raised funds invested in projects invested with raised funds in advance of RMB 30.544 million. For details, please refer to the website of Shanghai Stock Exchange (www.sse. Com. CN.) on July 2, 2021 The announcement on the adjustment of the amount of raised investment projects and the use of raised funds to replace self raised funds invested in raised investment projects in advance and paid issuance expenses (Announcement No.: 2021005).
As of December 31, 2021, the company has used the raised funds to replace the paid issuance expenses of RMB 3.1581 million and the self raised funds of RMB 30.544 million invested in the investment projects with raised funds in advance. The above replacement matters have been completed. (III) temporary replenishment of working capital with idle raised funds
In 2021, the company did not use idle raised funds to temporarily supplement working capital.
(IV) cash management and investment in related products with temporarily idle raised funds
On June 30, 2021, the company held the 17th meeting of the first board of directors and the 12th meeting of the first board of supervisors, deliberated and passed the proposal on using idle raised funds for cash management respectively, and agreed that the company, without affecting the construction and implementation of investment projects with raised funds, the use plan of raised funds and ensuring the safety of raised funds, Use the temporarily idle raised funds up to RMB 160 million for cash management, purchase investment products with high safety and good liquidity, and meet the principal guaranteed requirements (including but not limited to principal guaranteed financial products, structured deposits, time deposits, large certificates of deposit, circular deposits, agreed deposits, etc.). The service life is valid within 12 months from the date of deliberation and approval by the board of directors. Within the above limit and period, the funds are
It can be used circularly.
As of December 31, 2021, the company used some idle raised funds for cash management as follows:
Unit: 10000 yuan
Entrusted bank product name amount start time end time expected annualized rate of return whether to redeem
Guangdong Development Bank Fengxian sub branch structural deposit 5 China Vanke Co.Ltd(000002) 021 / 08 / 172021 / 11 / 16 1.00% or 3.30% or
3.45%
Guangdong Development Bank Fengxian sub branch structural deposit 5 China Vanke Co.Ltd(000002) 021 / 11 / 192022 / 05 / 18 1.3% or 3.30% or no
3.7%
China Merchants Bank Co.Ltd(600036) Fengxian sub branch certificate of deposit 1 China Vanke Co.Ltd(000002) 021 / 05 / 202021 / 09 / 03 3.78% yes
Bank Of Nanjing Co.Ltd(601009) Shanghai Branch certificate of deposit 1 China Vanke Co.Ltd(000002) 021 / 08 / 042024 / 08 / 04 3.55% no
Bank Of Nanjing Co.Ltd(601009) Shanghai Branch structural deposit 2 China Vanke Co.Ltd(000002) 021 / 08 / 062022 / 02 / 09 1.85% or 3.4% or no
3.7%
Bank Of Hangzhou Co.Ltd(600926) Shanghai Branch certificate of deposit 15 Shenzhen Zhongheng Huafa Co.Ltd(000020) 21 / 09 / 162022 / 01 / 24 3.55% no
Bank Of Hangzhou Co.Ltd(600926) Shanghai Branch structural deposit 800. Zoje Resources Investment Co.Ltd(002021) / 08 / 132021 / 11 / 18 1.5% – 3.2% yes
Bank Of Hangzhou Co.Ltd(600926) Shanghai Branch structured deposit 1270 Zoje Resources Investment Co.Ltd(002021) / 09 / 292021 / 11 / 29 1.5% – 2.7% yes
Bank Of Hangzhou Co.Ltd(600926) Shanghai Branch structured deposit 25 Shenzhen Zhongheng Huafa Co.Ltd(000020) 21 / 12 / 032022 / 02 / 25 1.5% – 3.2% no
(V) permanent replenishment of working capital or repayment of bank loans with over raised funds
In 2021, the company did not use over raised funds to permanently supplement working capital or repay bank loans
Situation.
(VI) use of over raised funds for projects under construction and new projects (including acquisition of assets, etc.)
In 2021, the company did not use the over raised funds for projects under construction and new projects (including the acquisition of assets)
The situation.
(VII) use of surplus raised funds
In 2021, the company did not use the surplus raised funds for investment projects.
(VIII) other information about the use of raised funds
In 2021, there was no other use of raised funds in the company.
4、 Change the use of funds for investment projects with raised funds
(I) change of investment projects with raised funds
In 2021, there was no change in the investment project of the company’s raised funds.
(II) external transfer or replacement of investment projects with raised funds
In 2021, there was no external transfer or replacement of the company’s investment projects with raised funds. 5、 Problems in the use and disclosure of raised funds
The company has timely, truthfully, accurately and completely disclosed the deposit and actual use of the company’s raised funds in accordance with the relevant provisions of the self regulatory guidelines for companies listed on the science and Innovation Board of Shanghai Stock Exchange No. 1 – standardized operation and the self regulatory guidelines for companies listed on Shanghai Stock Exchange No. 1 – announcement format, and there is no violation of the management of raised funds. The company has faithfully fulfilled its obligation to disclose the investment direction and progress of the raised funds. 6、 Verification opinions of the recommendation institution
After verification, the recommendation institution believes that the deposit and use of the company’s raised funds in 2021 comply with the measures for the administration of securities issuance and listing recommendation business and the guidelines for the supervision of listed companies No. 2 –
